首页 > 市场调查报告书 > 医疗设备

体外诊断

幽门螺旋桿菌（H. pylori）诊断市场规模、份额和成长分析（按检测类型、方法、最终用户和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1900109

幽门螺旋桿菌（H. pylori）诊断市场规模、份额和成长分析（按检测类型、方法、最终用户和地区划分）—产业预测（2026-2033 年）

Helicobacter pylori H. pylori Diagnostics Market Size, Share, and Growth Analysis, By Test Type (Invasive, Histology), By Method (Immunoassays, Molecular diagnostics), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球幽门螺旋桿菌（H. pylori）诊断市场规模预计在 2024 年达到 6.7475 亿美元，从 2025 年的 7.2131 亿美元增长到 2033 年的 12.3011 亿美元，在预测期（2026-2033 年）复合年增长率为 6.9%。

由于幽门螺旋桿菌诊断有助于提高诊断准确性、促进有效治疗并降低医疗成本，全球幽门螺旋桿菌诊断市场正蓬勃发展。透过先进的诊断检测进行早期发现对于预防疾病进展和减轻幽门螺旋桿菌感染相关併发症至关重要。创新非侵入性检测方法，例如血液检测、呼吸检测和粪便抗原检测，不仅为患者提供了更高的便利性和舒适度，而且经济实惠，从而促进了其更广泛的应用。这种高效的诊断使医疗服务提供者能够及时启动治疗，从而改善患者预后、缓解症状并加速溃疡癒合。此外，包括抗生素和抑酸剂在内的有效治疗方案在预防严重併发症、改善患者整体健康状况和生活品质方面发挥关键作用。

推动全球幽门螺旋桿菌诊断市场发展的因素

全球幽门螺旋桿菌诊断市场主要受幽门螺旋桿菌感染疾病在全球范围内高发生率的推动。据估计，近一半的人口受到这种广泛存在的细菌感染的影响。这种普遍性导致人们对精准诊断测试和有效治疗方案的需求日益增长。随着人们对幽门螺旋桿菌健康影响的认识不断提高，对可靠诊断和适当感染控制的需求也变得愈发迫切。因此，医疗服务提供者和患者都开始寻求能够实现及时介入的创新诊断方法，这凸显了扩大市场和丰富治疗选择的迫切性。

全球幽门螺旋桿菌诊断市场限制因素

全球幽门螺旋桿菌诊断市场的扩张面临许多挑战，其中之一是许多发展中地区医疗资源和诊断能力的匮乏。这些地区往往缺乏准确诊断和治疗幽门螺旋桿菌感染疾病所需的专业医疗设备和技术人员，限制了患者获得基本医疗保健服务的机会。这种医疗资源分配的不均可能导致这些地区的人们难以获得所需的医疗服务，最终从根本上影响幽门螺旋桿菌诊断的整体进展和发展，并严重阻碍市场成长。解决这些限制因素对于改善受影响地区的医疗保健状况至关重要。

全球幽门螺旋桿菌（H. pylori）诊断市场趋势

全球幽门螺旋桿菌（H. pylori）诊断市场正呈现出显着的趋势，即非侵入性检测方法，特别是血清学检测和尿素呼气试验，正日益普及。这项变化主要源自于患者对便利性、非侵入性检测方法的偏好，以及诊断技术的进步提高了检测的准确性和可靠性。随着医疗机构致力于改善患者体验和治疗效果，对这些非侵入性检测的需求激增，反映出人们对便捷高效诊断方法的普遍追求。这一趋势不仅有助于早期发现和治疗幽门螺旋桿菌感染疾病，也反映了全球民众对胃肠道健康的日益重视。

赛默飞世尔科技（美国）
Bio-Rad Laboratories（美国）
Meridian Bioscience（美国）
F. Hoffmann-La Roche Ltd.（瑞士）
Quest Diagnostics Incorporated（美国）
雅培实验室（美国）
生物梅里埃公司（法国）
康德乐公司（美国）
Epitope Diagnostics, Inc.（美国）
Biohit Oyj（芬兰）
Avanos Medical, Inc.（美国）
Quidel公司（美国）
迪亚索林公司（义大利）
安捷伦科技公司（美国）
美国实验室控股公司（LabCorp）（美国）
西门子医疗股份公司（德国）

结论与建议

简介目录

Product Code: SQMIG35A2188

Global Helicobacter pylori H. pylori Diagnostics Market size was valued at USD 674.75 Million in 2024 and is poised to grow from USD 721.31 Million in 2025 to USD 1230.11 Million by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global diagnostics market for Helicobacter pylori is gaining traction due to its role in enhancing diagnosis, enabling effective treatment, and lowering healthcare expenses. Early detection through advanced diagnostic tests is vital for preventing disease progression and mitigating complications associated with H. pylori infections. Innovative, non-invasive testing methods such as blood, breath, and stool antigen tests make detection accessible and comfortable for patients, while being cost-effective and increasing availability across broader demographics. This diagnostic efficiency allows healthcare providers to initiate timely treatment, yielding improved patient outcomes, symptom relief, and faster healing of ulcers. Additionally, effective treatment options, including antibiotics and acid-reducing medications, play a critical role in thwarting severe complications, thus enhancing patients' overall health and quality of life.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Helicobacter pylori H. pylori Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Helicobacter pylori H. pylori Diagnostics Market Segments Analysis

Global Helicobacter pylori H. pylori Diagnostics Market is segmented by Test Type, Method, End User and region. Based on Test Type, the market is segmented into Invasive, Histology, Rapid Urease Test, HP Culture, Non-Invasive, Serologic Test, Urea Breath Test and Stool Antigen Test. Based on Method, the market is segmented into Immunoassays, Molecular diagnostics, Point of Care (POC) and Others. Based on End User, the market is segmented into Hospitals, Clinics, Diagnostic Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Helicobacter pylori H. pylori Diagnostics Market

The global Helicobacter pylori diagnostics market is driven by the high incidence of H. pylori infections worldwide, with nearly half of the population estimated to be affected by this prevalent bacterial infection. This widespread occurrence has led to an increasing demand for accurate diagnostic tests and effective treatment solutions. As awareness of H. pylori's health implications grows, the need for reliable diagnosis and appropriate management of the infection becomes more critical. Consequently, healthcare providers and patients alike are seeking innovative diagnostics that can lead to timely interventions, underscoring the market's expansion and the urgency for enhanced treatment options.

Restraints in the Global Helicobacter pylori H. pylori Diagnostics Market

The expansion of the global H. pylori diagnostics market faces challenges due to inadequate healthcare resources and diagnostic capabilities in various developing regions. Access to specialized medical equipment and expertise needed for the accurate diagnosis and treatment of H. pylori infections is often scarce, limiting patient access to essential healthcare services. This disparity in availability can significantly hinder market growth, as individuals in these areas may struggle to receive the necessary medical attention, ultimately affecting the overall progress and development of H. pylori diagnostics on a broader scale. Addressing these constraints is crucial for improving healthcare outcomes in affected regions.

Market Trends of the Global Helicobacter pylori H. pylori Diagnostics Market

The Global Helicobacter pylori (H. pylori) diagnostics market is experiencing a significant trend towards increased adoption of non-invasive methods, particularly serology tests and urea breath tests. This shift is largely driven by patient preference for convenient and less invasive procedures, alongside advancements in diagnostic technology that enhance accuracy and reliability. As healthcare providers focus on improving patient experiences and outcomes, the demand for these non-invasive tests is surging, reflecting a broader movement towards accessible and efficient diagnostics. This trend not only facilitates early detection and treatment of H. pylori infections but also signifies a growing awareness of gastrointestinal health among populations worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Helicobacter pylori H. pylori Diagnostics Market Size by Test Type & CAGR (2026-2033)

Market Overview
Invasive
Histology
Rapid Urease Test
HP Culture
Non-Invasive
Serologic Test
Urea Breath Test
Stool Antigen Test

Global Helicobacter pylori H. pylori Diagnostics Market Size by Method & CAGR (2026-2033)

Market Overview
Immunoassays
Molecular diagnostics
Point of Care (POC)
Others

Global Helicobacter pylori H. pylori Diagnostics Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Clinics
Diagnostic Labs
Others

Global Helicobacter pylori H. pylori Diagnostics Market Size & CAGR (2026-2033)

North America (Test Type, Method, End User)
- US
- Canada
Europe (Test Type, Method, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Method, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Method, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Method, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epitope Diagnostics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biohit Oyj (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avanos Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (LabCorp) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments